メインコンテンツに移動

Regulatory uncertainty 'a barrier' to issuance of contingent capital by European insurers

Lack of clarity on Solvency II dampening investor interest, while Swiss insurers reap benefits of stable regime

Davos Switzerland

Uncertainty over the development of Solvency II is preventing European insurers from issuing contingent capital instruments, according to debt capital markets bankers.

The comments come in the wake of a $750 million (£502 million) contingent capital bond issued by Swiss Re.

Contingent capital instruments are generally debt instruments that convert into equity (known as contingent convertible or

コンテンツを印刷またはコピーできるのは、有料の購読契約を結んでいるユーザー、または法人購読契約の一員であるユーザーのみです。

これらのオプションやその他の購読特典を利用するには、info@risk.net にお問い合わせいただくか、こちらの購読オプションをご覧ください: http://subscriptions.risk.net/subscribe

現在、このコンテンツをコピーすることはできません。詳しくはinfo@risk.netまでお問い合わせください。

Sorry, our subscription options are not loading right now

Please try again later. Get in touch with our customer services team if this issue persists.

New to Risk.net? View our subscription options

Most read articles loading...

You need to sign in to use this feature. If you don’t have a Risk.net account, please register for a trial.

ログイン
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here